IRadimed Financial Statements From 2010 to 2026
| 46K Stock | EUR 86.50 2.50 2.98% |
Check IRadimed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IRadimed's main balance sheet or income statement drivers, such as , as well as many indicators such as . IRadimed financial statements analysis is a perfect complement when working with IRadimed Valuation or Volatility modules.
IRadimed |
IRadimed Company Current Valuation Analysis
IRadimed's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current IRadimed Current Valuation | 288.03 M |
Most of IRadimed's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IRadimed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, IRadimed has a Current Valuation of 288.03 M. This is 97.99% lower than that of the Healthcare sector and 97.68% lower than that of the Medical Devices industry. The current valuation for all Germany stocks is 98.27% higher than that of the company.
IRadimed Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IRadimed's current stock value. Our valuation model uses many indicators to compare IRadimed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IRadimed competition to find correlations between indicators driving IRadimed's intrinsic value. More Info.IRadimed is rated fourth in return on equity category among its peers. It is number one stock in return on asset category among its peers reporting about 0.66 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for IRadimed is roughly 1.52 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IRadimed's earnings, one of the primary drivers of an investment's value.About IRadimed Financial Statements
IRadimed stakeholders use historical fundamental indicators, such as IRadimed's revenue or net income, to determine how well the company is positioned to perform in the future. Although IRadimed investors may analyze each financial statement separately, they are all interrelated. For example, changes in IRadimed's assets and liabilities are reflected in the revenues and expenses on IRadimed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in IRadimed. Please read more on our technical analysis and fundamental analysis pages.
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging compatible medical devices, and related accessories and services in the United States and internationally. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida. IRADIMED CORP operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 110 people.
Currently Active Assets on Macroaxis
Other Information on Investing in IRadimed Stock
IRadimed financial ratios help investors to determine whether IRadimed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IRadimed with respect to the benefits of owning IRadimed security.